The vitamin D receptor as a potential target for the treatment of age-related neurodegenerative diseases such as Alzheimer's and Parkinson's diseases: A narrative …

W Lasoń, D Jantas, M Leśkiewicz, M Regulska… - Cells, 2023 - mdpi.com
The vitamin D receptor (VDR) belongs to the nuclear receptor superfamily of transcription
factors. The VDR is expressed in diverse brain regions and has been implicated in the …

Blood–brain barrier and neurodegenerative diseases—modeling with iPSC-derived brain cells

YC Wu, TM Sonninen, S Peltonen, J Koistinaho… - International journal of …, 2021 - mdpi.com
The blood–brain barrier (BBB) regulates the delivery of oxygen and important nutrients to
the brain through active and passive transport and prevents neurotoxins from entering the …

Astrocytic VEGFA: An essential mediator in blood–brain‐barrier disruption in Parkinson's disease

G Lan, P Wang, RB Chan, Z Liu, Z Yu, X Liu, Y Yang… - Glia, 2022 - Wiley Online Library
The integrity of blood–brain‐barrier (BBB) is essential for normal brain functions, synaptic
remodeling, and angiogenesis. BBB disruption is a common pathology during Parkinson's …

Vitamin D and neurodegenerative diseases

W Wang, Y Li, X Meng - Heliyon, 2023 - cell.com
Neurodegenerative diseases, featured by progressive loss of structure or function of
neurons, are considered incurable at present. Movement disorders like tremor and postural …

Targeting nuclear receptors in neurodegeneration and neuroinflammation

S Willems, D Zaienne, D Merk - Journal of medicinal chemistry, 2021 - ACS Publications
Nuclear receptors, also known as ligand-activated transcription factors, regulate gene
expression upon ligand signals and present as attractive therapeutic targets especially in …

Blood–brain barrier alterations and their impact on Parkinson's disease pathogenesis and therapy

K Lau, R Kotzur, F Richter - Translational neurodegeneration, 2024 - Springer
There is increasing evidence for blood–brain barrier (BBB) alterations in Parkinson's
disease (PD), the second most common neurodegenerative disorder with rapidly rising …

Transporter regulation in critical protective barriers: focus on brain and placenta

V Taggi, M Riera Romo, M Piquette-Miller… - Pharmaceutics, 2022 - mdpi.com
Drug transporters play an important role in the maintenance of chemical balance and
homeostasis in different tissues. In addition to their physiological functions, they are crucial …

Linking nonalcoholic fatty liver disease and brain disease: Focusing on bile acid signaling

ZL Ren, CX Li, CY Ma, D Chen, JH Chen… - International Journal of …, 2022 - mdpi.com
A metabolic illness known as non-alcoholic fatty liver disease (NAFLD), affects more than
one-quarter of the world's population. Bile acids (BAs), as detergents involved in lipid …

The role of the efflux transporter, P‐glycoprotein, at the blood–brain barrier in drug discovery

B Cox, J Nicolaï, B Williamson - Biopharmaceutics & Drug …, 2023 - Wiley Online Library
The blood–brain barrier (BBB) expresses a high abundance of transporters, particularly P‐
glycoprotein (P‐gp), that regulate endogenous and exogenous molecule uptake and …

ATP-binding cassette transporters and neurodegenerative diseases

JS Katzeff, WS Kim - Essays in Biochemistry, 2021 - portlandpress.com
ATP-binding cassette (ABC) transporters are one of the largest groups of transporter families
in humans. ABC transporters mediate the translocation of a diverse range of substrates …